{"id":"https://openalex.org/W2324674323","doi":"https://doi.org/10.3851/imp1844","title":"Synthesis of 1-benzyl-3-(3,5-dimethylbenzyl)Uracil Derivatives with Potential Anti-HIV Activity","display_name":"Synthesis of 1-benzyl-3-(3,5-dimethylbenzyl)Uracil Derivatives with Potential Anti-HIV Activity","publication_year":2011,"publication_date":"2011-07-07","ids":{"openalex":"https://openalex.org/W2324674323","doi":"https://doi.org/10.3851/imp1844","mag":"2324674323","pmid":"https://pubmed.ncbi.nlm.nih.gov/21984685"},"language":"en","primary_location":{"id":"doi:10.3851/imp1844","doi":"https://doi.org/10.3851/imp1844","is_oa":true,"landing_page_url":"https://doi.org/10.3851/imp1844","pdf_url":"https://journals.sagepub.com/doi/pdf/10.3851/IMP1844","source":{"id":"https://openalex.org/S201936961","display_name":"Antiviral chemistry & chemotherapy","issn_l":"0956-3202","issn":["0956-3202","2040-2066"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral Chemistry and Chemotherapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://journals.sagepub.com/doi/pdf/10.3851/IMP1844","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5080498315","display_name":"Yohei Isono","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I89098413","display_name":"Tokushima Bunri University","ror":"https://ror.org/00smwky98","country_code":"JP","type":"education","lineage":["https://openalex.org/I89098413"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yohei Isono","raw_affiliation_strings":["Faculty of Pharmaceutical Sciences at Kagawa Campus, Tokushima Bunri University, Sanuki City, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmaceutical Sciences at Kagawa Campus, Tokushima Bunri University, Sanuki City, Japan","institution_ids":["https://openalex.org/I89098413"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027605731","display_name":"Norikazu Sakakibara","orcid":"https://orcid.org/0000-0003-4590-0662","observed_orcids":["https://orcid.org/0000-0003-4590-0662"]},"institutions":[{"id":"https://openalex.org/I89098413","display_name":"Tokushima Bunri University","ror":"https://ror.org/00smwky98","country_code":"JP","type":"education","lineage":["https://openalex.org/I89098413"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Norikazu Sakakibara","raw_affiliation_strings":["Faculty of Pharmaceutical Sciences at Kagawa Campus, Tokushima Bunri University, Sanuki City, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmaceutical Sciences at Kagawa Campus, Tokushima Bunri University, Sanuki City, Japan","institution_ids":["https://openalex.org/I89098413"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012734301","display_name":"Paula Ordonez","orcid":"https://orcid.org/0000-0001-5588-5369","observed_orcids":["https://orcid.org/0000-0001-5588-5369"]},"institutions":[{"id":"https://openalex.org/I107139324","display_name":"Kagoshima University","ror":"https://ror.org/03ss88z23","country_code":"JP","type":"education","lineage":["https://openalex.org/I107139324"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Paula Ordonez","raw_affiliation_strings":["Division of Antiviral Chemotherapy, Center for Chronic Viral Diseases, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Antiviral Chemotherapy, Center for Chronic Viral Diseases, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan","institution_ids":["https://openalex.org/I107139324"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008321984","display_name":"Takayuki Hamasaki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I107139324","display_name":"Kagoshima University","ror":"https://ror.org/03ss88z23","country_code":"JP","type":"education","lineage":["https://openalex.org/I107139324"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takayuki Hamasaki","raw_affiliation_strings":["Division of Antiviral Chemotherapy, Center for Chronic Viral Diseases, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Antiviral Chemotherapy, Center for Chronic Viral Diseases, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan","institution_ids":["https://openalex.org/I107139324"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080592581","display_name":"Masanori Baba","orcid":"https://orcid.org/0000-0002-6109-5248","observed_orcids":["https://orcid.org/0000-0002-6109-5248"]},"institutions":[{"id":"https://openalex.org/I107139324","display_name":"Kagoshima University","ror":"https://ror.org/03ss88z23","country_code":"JP","type":"education","lineage":["https://openalex.org/I107139324"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masanori Baba","raw_affiliation_strings":["Division of Antiviral Chemotherapy, Center for Chronic Viral Diseases, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Antiviral Chemotherapy, Center for Chronic Viral Diseases, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan","institution_ids":["https://openalex.org/I107139324"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054251050","display_name":"Masahiro Ikejiri","orcid":"https://orcid.org/0000-0001-8585-4969","observed_orcids":["https://orcid.org/0000-0001-8585-4969"]},"institutions":[{"id":"https://openalex.org/I167598709","display_name":"Osaka Ohtani University","ror":"https://ror.org/01jtn9895","country_code":"JP","type":"education","lineage":["https://openalex.org/I167598709"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masahiro Ikejiri","raw_affiliation_strings":["Faculty of Pharmacy, Osaka Ohtani University, Tondabayashi, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmacy, Osaka Ohtani University, Tondabayashi, Japan","institution_ids":["https://openalex.org/I167598709"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101118951","display_name":"Tokumi Maruyama","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I89098413","display_name":"Tokushima Bunri University","ror":"https://ror.org/00smwky98","country_code":"JP","type":"education","lineage":["https://openalex.org/I89098413"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tokumi Maruyama","raw_affiliation_strings":["Faculty of Pharmaceutical Sciences at Kagawa Campus, Tokushima Bunri University, Sanuki City, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmaceutical Sciences at Kagawa Campus, Tokushima Bunri University, Sanuki City, Japan","institution_ids":["https://openalex.org/I89098413"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":1500,"currency":"USD","value_usd":1500},"apc_paid":null,"fwci":1.0852,"has_fulltext":true,"cited_by_count":16,"citation_normalized_percentile":{"value":0.7530338,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"22","issue":"2","first_page":"57","last_page":"65"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.003599999938160181,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/uracil-analogues","display_name":"uracil analogues","score":0.9259999990463257},{"id":"https://openalex.org/keywords/hiv-1-reverse-transcriptase-inhibitors","display_name":"HIV-1 reverse transcriptase inhibitors","score":0.9200000166893005},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.878000020980835},{"id":"https://openalex.org/keywords/antiviral-activity","display_name":"antiviral activity","score":0.6959999799728394},{"id":"https://openalex.org/keywords/5-fluorouracil-derivatives","display_name":"5-fluorouracil derivatives","score":0.8500000238418579},{"id":"https://openalex.org/keywords/non-nucleoside-reverse-transcriptase-inhibitor-resistance","display_name":"non-nucleoside reverse transcriptase inhibitor resistance","score":0.8299999833106995},{"id":"https://openalex.org/keywords/selectivity-index","display_name":"selectivity index","score":0.4880000054836273}],"concepts":[{"id":"https://openalex.org/C2779554091","wikidata":"https://www.wikidata.org/wiki/Q182990","display_name":"Uracil","level":3,"score":0.9193698763847351},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.6490172147750854},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6451928019523621},{"id":"https://openalex.org/C164361826","wikidata":"https://www.wikidata.org/wiki/Q177604","display_name":"Alkylation","level":3,"score":0.47747111320495605},{"id":"https://openalex.org/C2776543447","wikidata":"https://www.wikidata.org/wiki/Q28734","display_name":"Nucleoside","level":2,"score":0.42490875720977783},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.23200654983520508},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.1572112739086151},{"id":"https://openalex.org/C161790260","wikidata":"https://www.wikidata.org/wiki/Q82264","display_name":"Catalysis","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006860","descriptor_name":"Hydrogen Bonding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014498","descriptor_name":"Uracil","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D014498","descriptor_name":"Uracil","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.3851/imp1844","doi":"https://doi.org/10.3851/imp1844","is_oa":true,"landing_page_url":"https://doi.org/10.3851/imp1844","pdf_url":"https://journals.sagepub.com/doi/pdf/10.3851/IMP1844","source":{"id":"https://openalex.org/S201936961","display_name":"Antiviral chemistry & chemotherapy","issn_l":"0956-3202","issn":["0956-3202","2040-2066"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral Chemistry and Chemotherapy","raw_type":"journal-article"},{"id":"pmid:21984685","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21984685","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral chemistry & chemotherapy","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.3851/imp1844","doi":"https://doi.org/10.3851/imp1844","is_oa":true,"landing_page_url":"https://doi.org/10.3851/imp1844","pdf_url":"https://journals.sagepub.com/doi/pdf/10.3851/IMP1844","source":{"id":"https://openalex.org/S201936961","display_name":"Antiviral chemistry & chemotherapy","issn_l":"0956-3202","issn":["0956-3202","2040-2066"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral Chemistry and Chemotherapy","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8199999928474426,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2324674323.pdf","grobid_xml":"https://content.openalex.org/works/W2324674323.grobid-xml"},"referenced_works_count":21,"referenced_works":["https://openalex.org/W233628489","https://openalex.org/W1570283533","https://openalex.org/W1969602785","https://openalex.org/W1985555372","https://openalex.org/W2017436619","https://openalex.org/W2025242673","https://openalex.org/W2035061658","https://openalex.org/W2050263615","https://openalex.org/W2050605469","https://openalex.org/W2051893599","https://openalex.org/W2057271711","https://openalex.org/W2063825413","https://openalex.org/W2071189977","https://openalex.org/W2088467075","https://openalex.org/W2136008225","https://openalex.org/W2142992472","https://openalex.org/W2167849207","https://openalex.org/W2181643390","https://openalex.org/W2462885022","https://openalex.org/W2950026923","https://openalex.org/W4296370709"],"related_works":["https://openalex.org/W3172344025","https://openalex.org/W2082861854","https://openalex.org/W2100893395","https://openalex.org/W7095246806","https://openalex.org/W1999118223","https://openalex.org/W2049935537","https://openalex.org/W2167849207","https://openalex.org/W2076990166","https://openalex.org/W2058463950","https://openalex.org/W1971195382"],"abstract_inverted_index":{"BACKGROUND:":[0],"Nine":[1],"novel":[2,113],"uracil":[3,49,52,78,92,108],"analogues":[4,79],"were":[5,53],"synthesized":[6,77],"and":[7,50,61,64,69,93,109,125],"evaluated":[8],"as":[9,112,129,131],"inhibitors":[10],"of":[11,19,23,31,46,83,90,96],"HIV-1.":[12],"METHODS:":[13],"Key":[14],"structural":[15],"modifications":[16],"included":[17],"replacement":[18],"the":[20,75,81,84],"6-chloro":[21],"group":[22,89,95],"1-benzyl-6-chloro-3-(3,5-dimethylbenzyl)uracil":[24],"by":[25],"other":[26],"functional":[27],"groups":[28],"or":[29],"N(1)-alkylation":[30],"3-(3,5-dimethylbenzyl)-5-fluorouracil.":[32],"RESULTS:":[33],"These":[34,116],"compounds":[35,117],"showed":[36],"only":[37],"micromolar":[38],"potency":[39],"against":[40,134],"HIV-1":[41,97],"in":[42,127],"MT-4,":[43],"though":[44],"two":[45,103],"them;":[47],"6-azido-1-benzyl-3-(3,5-dimethylbenzyl)":[48],"6-amino-1-benzyl-3-(3,5-dimethylbenzyl)":[51,91,110],"highly":[54],"potent":[55],"(half":[56],"maximal":[57],"effective":[58],"concentration":[59],"=0.067":[60],"0.069":[62],"\u03bcM)":[63],"selective":[65],"(selectivity":[66],"index":[67],"=685":[68],"661),":[70],"respectively.":[71],"Structure-activity":[72],"relationships":[73],"among":[74],"newly":[76],"suggest":[80],"importance":[82],"H-bond":[85],"formed":[86],"between":[87],"6-amino":[88],"amide":[94],"reverse":[98,136],"transcriptase.":[99],"CONCLUSIONS:":[100],"We":[101],"discovered":[102],"6-substituted":[104],"1-benzyl-3-(3,5-dimethylbenzyl)":[105],"uracils,":[106],"(6-azido-1-benzyl-3-(3,5-dimethylbenzyl)":[107],"uracil)":[111],"anti-HIV":[114],"agents.":[115],"should":[118],"be":[119],"further":[120],"pursued":[121],"for":[122],"their":[123],"toxicity":[124],"pharmacokinetics":[126],"vivo":[128],"well":[130],"antiviral":[132],"activity":[133],"non-nucleoside":[135],"transcriptase":[137],"inhibitor-resistant":[138],"strains.":[139]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}